The Grey Terminal
WHERE CODE MEETS CAPITAL
Loading prices…
Powered by CoinGecko
Business & Venture

A Nagoya Front Company, a Fake Token, and a Fentanyl Network

A Chinese network tied to fentanyl precursor trafficking appears to have used a Nagoya front company and a fake token to run crypto fraud.

A Nagoya Front Company, a Fake Token, and a Fentanyl Network

The fake token was only the surface. Behind it was a Chinese network suspected of moving fentanyl precursors, operating through a Nagoya front company, and using Japan’s credibility to make fraud look legitimate.

Key Takeaways
  • Hubei Amarvel Biotech utilizes Nagoya front company Firsky to coordinate fentanyl precursor trafficking and multi-million yen cryptocurrency fraud operations.
  • Fraudsters exploit the zksync.jp domain to steal hundreds of millions of yen before the group's Japanese logistics hub liquidated in 2024.
  • Criminal syndicates weaponize Japanese corporate credibility to bypass international financial scrutiny and facilitate illicit cross-border shipments of chemical precursors.
Listen to this article
READY

The case links Hubei Amarvel Biotech, a Wuhan-based chemical company, to U.S. convictions over fentanyl precursor imports and money laundering. Prosecutors said the company shipped large quantities of precursor chemicals to the United States and used cryptocurrency in parts of the operation.

The Amarvel case showed a network built to move goods, money and information across borders. Nikkei’s reporting suggests the same structure also supported a separate crypto fraud scheme.

The Japan Link

Nikkei reported that the group used Firsky, a Nagoya-based company, as a base for logistics and fund management, and possibly for fraud. A Chinese national described as the “boss in Japan” was also linked to the operation before Firsky was liquidated in 2024.

Japan appears to have mattered because it offered credibility. A Japanese company, a Japanese address and a .jp domain can all make a fraud operation seem more legitimate to outsiders.

Advertisement · Press Release

Have a development worth tracking?

Share product launches, funding announcements, partnerships, research findings and market developments with The Grey Terminal's readership.

→ Submit a Press Release

That credibility appears to have been part of the design. The Japan connection was not just geographic; it helped frame the operation in a way that made it harder to question.

The Fake Token

The fraudulent token, zksync.jp, borrowed from the naming logic of legitimate crypto projects while having no connection to the real zkSync network. The use of a familiar-sounding name and a Japanese domain gave the token an added layer of apparent legitimacy.

According to the reporting, victims in Japan and elsewhere were persuaded to send funds, with losses estimated in the hundreds of millions of yen. The scale matters, but the method matters more: the token relied on borrowed trust rather than technical sophistication.

That is what makes the case notable. It shows how a fraud can be built from recognizable signals rather than complex code.

A Broader Pattern

The story points to a network that appears able to move between physical shipments and digital fraud while relying on the same methods of concealment. It also reflects a wider pattern in which Chinese networks use jurisdictions, shell companies and local-facing branding to build trust.

That makes the Japan link more than a detail. It shows how credibility itself can become part of the infrastructure of a scheme.

The Grey Terminal Note 

The fake token was not the core story. The real story is a network that used a Nagoya front company and Japan’s credibility to make its operations look legitimate. It moved between chemical shipments, fund management and crypto fraud using the same basic setup: shell companies, local cover and borrowed trust.

TERMINAL LAYER

Activate Terminal Layer

Structural analysis of the systems, pressures, and stakeholders behind this story.

FAQ

Frequently Asked Questions

01

What is the zksync.jp fraudulent token?

It's a malicious asset used by a Chinese criminal network to defraud investors by impersonating the legitimate zkSync protocol. The scammers registered a Japanese .jp domain to project false credibility and attract retail capital. This specific token has no technical or official connection to the real Ethereum scaling network.
02

Why does this matter for the Japanese financial sector?

Illicit networks are weaponizing Japan's international reputation for trust to mask fentanyl precursor trafficking and money laundering operations. The use of a Nagoya front company called Firsky allowed Hubei Amarvel Biotech to bypass standard oversight. This exploitation of Japanese corporate identity threatens the integrity of domestic business registries and digital asset markets.
03

How did Hubei Amarvel Biotech execute the Nagoya operation?

The Wuhan-based chemical firm established Firsky as a logistics and fund management hub before its liquidation in 2024. Operatives used this base to manage chemical shipments and funnel hundreds of millions of yen through the zksync.jp scam. U.S. prosecutors secured convictions against Amarvel leadership for importing fentanyl precursors using these crypto-linked channels.
04

What are the risks of using front companies for crypto fraud?

Front companies provide a layer of institutional cover that makes fraudulent tokens appear verified to unsuspecting retail traders. The zksync.jp case proves that recognizable signals like a local address are more effective than complex code for stealing funds. These structures allow transnational syndicates to move between physical drug trafficking and digital theft with minimal detection.
05

How will regulators detect similar Chinese chemical networks?

Authorities must now monitor the intersection of industrial chemical exports and shell company registrations in credible jurisdictions like Japan. The Amarvel case highlights the need for stricter verification of .jp domains and corporate liquidations involving foreign nationals. Future enforcement relies on cross-border intelligence sharing to disrupt the logistics of the global synthetic drug trade.

You Might Also Like

THE GREY TERMINAL
🛡
Alex Reeve

Alex Reeve is a contributing writer for The Grey Terminal Her articles provide timely insights and analysis across these interconnected industries, including regulatory updates, market trends, token economics, institutional developments, platform innovations, stablecoins, meme coins, policy shifts, and the latest advancements in AI, applications, tools, models, and their broader implications for technology and markets.

The views and opinions expressed by the author in this article are her own and do not necessarily reflect the official position of The Grey Terminal, its management, editors, or affiliates. This content is provided for informational and educational purposes only and does not constitute financial, investment, legal, or tax advice. Readers should conduct their own research and consult qualified professionals before making any decisions related to digital assets, cryptocurrencies, or financial matters. The Grey Terminal and its contributors are not responsible for any losses incurred from reliance on this information.